4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole → N-(2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)acetamide
반응식
[CH3:21][C:22]1([CH3:23])[C:24]([CH3:25])([CH3:26])[O:27][B:28]([c:29]2[c:30]3[cH:31][n:32][nH:33][c:34]3[cH:35][cH:36][cH:37]2)[O:38]1.[Cl:1][c:2]1[n:3][c:4]([N:15]2[CH2:16][CH2:17][O:18][CH2:19][CH2:20]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([NH:11][C:12]([CH3:13])=[O:14])[s:10]2>>[c:2]1(-[c:29]2[c:30]3[cH:31][n:32][nH:33][c:34]3[cH:35][cH:36][cH:37]2)[n:3][c:4]([N:15]2[CH2:16][CH2:17][O:18][CH2:19][CH2:20]2)[c:5]2[c:6]([n:7]1)[cH:8][c:9]([NH:11][C:12]([CH3:13])=[O:14])[s:10]2참가 물질
3
출처 및 근거
- ORD 기록
- ord-f180700450604cad9ccf4c4a88b24689
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (5/10)
반응 노트
불러오는 중…